CytomX Q2 2025 presentation slides: CX-2051 shows promising Phase 1 results in CRC

Related
Asia stocks mixed as Trump tariff uncertainty lingers; China...
19 minutes ago
0
Apple in talks for Formula 1 rights in U.S. after movie succ...
34 minutes ago
0
China CPI sees slight rise up 0.1%, PPI drops most in two ye...
50 minutes ago
0
Coca-Cola FEMSA declares $0.9877 dividend
1 hour ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved